Disc Medicine, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-59.5M | $-63.5M | $-60.5M | $-62.3M | $-55.2M | $-34.1M | $-29.5M | $-26.6M |
| Depreciation & Amortization | $90.0K | $89.0K | $89.0K | $87.0K | $85.0K | $20.0K | $9.0K | $11.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $13.9M | $11.9M | $10.0M | $9.5M | $8.4M | $6.4M | $4.3M | $4.3M |
| Net Cash from Operating Activities | $-44.2M | $-62.2M | $-43.3M | $-47.8M | $-47.9M | $-41.4M | $-27.6M | $-17.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $20.0K | $26.0K | $36.0K | $851.0K | $449.0K | $-8.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $21.6M | $58.3M | $-222.9M | $49.5M | $51.7M | $-272.6M | $-1.4M | $-71.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $32.3M | $1.7M | $216.7M | $11.6M | $892.0K | $244.3M | $28.8M | $426.0K |
| Net Change in Cash | $9.8M | $-2.2M | $-49.5M | $13.3M | $4.7M | $-69.8M | $-202.0K | $-88.0M |
| Free Cash Flow | $-44.2M | $-62.2M | $-43.3M | $-47.8M | $-48.0M | $-42.2M | $-28.0M | $-17.4M |